James T Anderson

Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms

Tytus D. Mak, S. Hazen, A. Keshavarzian, 2020, bioRxiv.

Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes

V. Tremaroli, F. Bäckhed, S. Hazen, 2023, iScience.

Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice

Daniel M. Rotroff, S. Hazen, D. Rotroff, 2022, bioRxiv.

Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors

S. N. Naga Prasad, M. Mohan, J. DiDonato, 2024, Nature communications.

A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk.

I. Demuth, H. Allayee, J. Hartiala, 2024, Nature medicine.